ARCHIVES

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

NCI Approved CTEP Trials For the Month of August

August 31, 2012

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials

May 10, 2002

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

Breast Cancer Risk Prediction Improved In Atypia Cases

July 27, 2007